Satisfaction Survey for Amyotrophic Lateral Sclerosis (ALS) Patients Comparing Rooms With and Without Assistive Technology
This study has been terminated.
(The study was discontinued due to low enrollment. A survey has been implemented in place of a formal study.)
Sponsor:
Drexel University College of Medicine
Collaborator:
MDA/ALS Center of Hope
Information provided by (Responsible Party):
Drexel University ( Drexel University College of Medicine )
ClinicalTrials.gov Identifier:
NCT00718107
First received: July 14, 2008
Last updated: March 1, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is :
- To assess the ALS patient's satisfaction related to a hospital stay on the neurology floor of Hahnemann Hospital.
- To compare the reported satisfaction of those individuals who stayed in a standard hospital room with those who stayed in Room 1455. Room 1455 is a room specifically set up with assistive technology related to environmental controls for individuals with disabilities.
- To look at frequency of use of the various pieces of adaptive equipment.
| Condition |
|---|
|
Amyotrophic Lateral Sclerosis Neurodegenerative Disease Motor Neuron Disease |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Cross-Sectional |
| Official Title: | Satisfaction Survey for ALS Patients Comparing Rooms With and Without Assistive Technology |
Resource links provided by NLM:
Further study details as provided by Drexel University:
Primary Outcome Measures:
- Patient Satisfaction [ Time Frame: Period of Hospital Stay ]Survey administered asks patients to rate their satisfaction with their hospital stay from Very Dissatisfied to Very Satisfied. Specific questions included satisfaction with hospital staff, quality of care, and comfort and accessibility of their room.
| Enrollment: | 5 |
| Study Start Date: | June 2005 |
| Study Completion Date: | February 2012 |
| Primary Completion Date: | February 2012 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
ALS
Subjects having either definite or probable ALS by El Escorial Criteria.
|
Eligibility| Ages Eligible for Study: | 18 Years to 90 Years (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
In-patients from the neurology floor of Hahnemann Hospital
Criteria
Inclusion Criteria:
- In-patients with probable or definite ALS, ages 18 - 90, staying on the neurology floor of Hahnemann Hospital
Exclusion Criteria:
- In-patients who do not meet the criteria of the diagnosis of ALS.
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00718107
Please refer to this study by its ClinicalTrials.gov identifier: NCT00718107
Locations
| United States, Pennsylvania | |
| MDA/ALS Center of Hope | |
| Philadelphia, Pennsylvania, United States, 19107 | |
Sponsors and Collaborators
Drexel University College of Medicine
MDA/ALS Center of Hope
More Information
| Responsible Party: | Drexel University College of Medicine |
| ClinicalTrials.gov Identifier: | NCT00718107 History of Changes |
| Other Study ID Numbers: |
Internal-15894 |
| Study First Received: | July 14, 2008 |
| Last Updated: | March 1, 2013 |
Keywords provided by Drexel University:
|
Amyotrophic Lateral Sclerosis Cerebrospinal Fluid Neurodegenerative Disease Motor Neuron Disease |
Autonomic Nervous System Neurodegenerative Diseases Movement Disorders Quality of Life |
Additional relevant MeSH terms:
|
Sclerosis Motor Neuron Disease Amyotrophic Lateral Sclerosis Neurodegenerative Diseases Pathologic Processes Nervous System Diseases |
Neuromuscular Diseases Spinal Cord Diseases Central Nervous System Diseases TDP-43 Proteinopathies Proteostasis Deficiencies Metabolic Diseases |
ClinicalTrials.gov processed this record on May 25, 2017